294 related articles for article (PubMed ID: 24381724)
1. The future role of gut hormones in the treatment of obesity.
Troke RC; Tan TM; Bloom SR
Ther Adv Chronic Dis; 2014 Jan; 5(1):4-14. PubMed ID: 24381724
[TBL] [Abstract][Full Text] [Related]
2. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
3. Gut hormones: implications for the treatment of obesity.
Neary MT; Batterham RL
Pharmacol Ther; 2009 Oct; 124(1):44-56. PubMed ID: 19560488
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
Nielsen MS; Ritz C; Wewer Albrechtsen NJ; Holst JJ; le Roux CW; Sjödin A
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016415
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome.
Alexiadou K; Tan TM
Curr Diab Rep; 2020 May; 20(7):26. PubMed ID: 32436022
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal hormones and bariatric surgery-induced weight loss.
Ionut V; Burch M; Youdim A; Bergman RN
Obesity (Silver Spring); 2013 Jun; 21(6):1093-103. PubMed ID: 23512841
[TBL] [Abstract][Full Text] [Related]
7. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal hormones and their role in obesity.
Choudhury SM; Tan TM; Bloom SR
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):18-22. PubMed ID: 26702847
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
[TBL] [Abstract][Full Text] [Related]
10. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
Lean ME; Malkova D
Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
[TBL] [Abstract][Full Text] [Related]
11. Gut hormones as therapeutic agents in treatment of diabetes and obesity.
Tan T; Bloom S
Curr Opin Pharmacol; 2013 Dec; 13(6):996-1001. PubMed ID: 24060699
[TBL] [Abstract][Full Text] [Related]
12. Gut peptides and the regulation of appetite.
Huda MS; Wilding JP; Pinkney JH
Obes Rev; 2006 May; 7(2):163-82. PubMed ID: 16629873
[TBL] [Abstract][Full Text] [Related]
13. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
Wynne K; Bloom SR
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):612-20. PubMed ID: 17082808
[TBL] [Abstract][Full Text] [Related]
14. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.
Small CJ; Bloom SR
Expert Opin Investig Drugs; 2005 May; 14(5):647-53. PubMed ID: 15926870
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery - time to replace with GLP-1?
Webb DL; Abrahamsson N; Sundbom M; Hellström PM
Scand J Gastroenterol; 2017; 52(6-7):635-640. PubMed ID: 28276830
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Gastrointestinal Hormones.
Albrechtsen NJW
Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115211
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.
Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Pilitsi E; Upadhyay J; Alexandrou A; Mantzoros CS
Metabolism; 2019 Dec; 101():153997. PubMed ID: 31672446
[TBL] [Abstract][Full Text] [Related]
19. Cracking the combination: Gut hormones for the treatment of obesity and diabetes.
Alexiadou K; Anyiam O; Tan T
J Neuroendocrinol; 2019 May; 31(5):e12664. PubMed ID: 30466162
[TBL] [Abstract][Full Text] [Related]
20. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
